The Emperor of All Maladies Summary

Siddhartha Mukherjee’s Pulitzer Prize-winning "The Emperor of All Maladies: A Biography of Cancer" (2010) treats cancer not as a single disease but as a shapeshifting antagonist with a deep evolutionary history. Mukherjee, an oncologist, structures the book as a biography spanning four thousand years, opening with ancient Egyptian records and Persian physician Galen’s theory of black bile before moving to the nineteenth-century rise of surgery under William Halsted’s radical mastectomy. The narrative then follows the twentieth century’s shifting battlefronts: Sidney Farber’s use of antifolates to induce remission in childhood leukemia, the environmental and epidemiological turn marked by Doll and Hill’s smoking-lung cancer link, and the political launch of the War on Cancer in 1971. Mukherjee foregrounds the science of oncogenes and tumor suppressor genes, explaining how mutations in genes like RAS, MYC, and p53 drive uncontrolled cell division, and he traces the emergence of targeted therapies such as imatinib for chronic myeloid leukemia. He also profiles key figures, including Mary Lasker’s advocacy and Donald Pinkel’s combination chemotherapy for acute lymphoblastic leukemia. The book blends patient stories with laboratory history, arguing that cancer is not a foreign invader but a corrupted version of our own cells, shaped by evolution and aging. It details both triumphs and failures, including the limitations of early chemotherapy and the later recognition that cancers adapt and resist treatment. Mukherjee’s central framework is that cancer is a disease of the genome, and the biography format lets him show how each era’s tools—scalpels, radiation, drugs, and molecular biology—reframed the enemy without ever fully defeating it.